Company reaches next clinical trial milestone for treatment of Type 1 Diabetes with the first novel allogenic cellular therapy in the dorsal artery of the pancreas in the United States
https://finance.yahoo.com/news/creative-medical-technology-holdings-announces-130000467.html
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.